S06-01设定场景:发育和生殖毒性研究的剂量水平选择

IF 2.9 3区 医学 Q2 TOXICOLOGY
F. Sewell
{"title":"S06-01设定场景:发育和生殖毒性研究的剂量水平选择","authors":"F. Sewell","doi":"10.1016/j.toxlet.2025.07.061","DOIUrl":null,"url":null,"abstract":"<div><div>Following advice on dose selection issued by the European Chemicals Agency (ECHA) in 2022 <span><span><sup>[1]</sup></span></span> for reproductive toxicity studies conducted under REACH, this presentation will cover the implications of this advice from both a 3Rs (Replacement, Reduction and Refinement of animals in research) and scientific perspective. The ECHA advice followed an evaluation of existing extended one generation reproductive toxicity (EOGRT) studies with respect to design, conduct and toxicological findings, and concerns that potential hazardous effects could be missed due to inadequate dosing. The resulting advice specified that the highest dose tested should <em>“demonstrate an aim to induce clear evidence of reproductive toxicity without excessive other toxicity and severe suffering in parental animals (e.g. prostration, severe inappetence (lack of appetite), excessive mortality as signs of severe suffering) that would compromise the interpretation of co-occurring reproductive effects.”</em> These recommendations have been evaluated by a number of expert groups, including the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Task Force on Dose Selection <span><span><sup>[2]</sup></span></span>, in relation to advice in existing Organisation for Economic Cooperation and Development (OECD) test guidelines and guidance document, including on humane endpoints and selection of the maximum tolerated dose. Other considerations relevant to dose selection include factors such as maternal clinical signs of toxicity, food consumption/nutritional intake, clinical chemistry parameters, circulatory/cardiovascular changes, target organ toxicity, maternal stress and toxicokinetics. The results of these evaluations, as well as recent discussions with ECHA and the wider scientific community (including at the EUROTOX 2024 satellite session <sup>[3]</sup>) which aimed to better understand the advice, will be presented, recognising a shared goal of ensuring a high level of human health protection whilst balancing scientific pragmatism and impact on animal welfare.</div></div>","PeriodicalId":23206,"journal":{"name":"Toxicology letters","volume":"411 ","pages":"Pages S19-S20"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"S06-01 Setting the scene: Dose level selection for development and reproductive toxicity studies\",\"authors\":\"F. Sewell\",\"doi\":\"10.1016/j.toxlet.2025.07.061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Following advice on dose selection issued by the European Chemicals Agency (ECHA) in 2022 <span><span><sup>[1]</sup></span></span> for reproductive toxicity studies conducted under REACH, this presentation will cover the implications of this advice from both a 3Rs (Replacement, Reduction and Refinement of animals in research) and scientific perspective. The ECHA advice followed an evaluation of existing extended one generation reproductive toxicity (EOGRT) studies with respect to design, conduct and toxicological findings, and concerns that potential hazardous effects could be missed due to inadequate dosing. The resulting advice specified that the highest dose tested should <em>“demonstrate an aim to induce clear evidence of reproductive toxicity without excessive other toxicity and severe suffering in parental animals (e.g. prostration, severe inappetence (lack of appetite), excessive mortality as signs of severe suffering) that would compromise the interpretation of co-occurring reproductive effects.”</em> These recommendations have been evaluated by a number of expert groups, including the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Task Force on Dose Selection <span><span><sup>[2]</sup></span></span>, in relation to advice in existing Organisation for Economic Cooperation and Development (OECD) test guidelines and guidance document, including on humane endpoints and selection of the maximum tolerated dose. Other considerations relevant to dose selection include factors such as maternal clinical signs of toxicity, food consumption/nutritional intake, clinical chemistry parameters, circulatory/cardiovascular changes, target organ toxicity, maternal stress and toxicokinetics. The results of these evaluations, as well as recent discussions with ECHA and the wider scientific community (including at the EUROTOX 2024 satellite session <sup>[3]</sup>) which aimed to better understand the advice, will be presented, recognising a shared goal of ensuring a high level of human health protection whilst balancing scientific pragmatism and impact on animal welfare.</div></div>\",\"PeriodicalId\":23206,\"journal\":{\"name\":\"Toxicology letters\",\"volume\":\"411 \",\"pages\":\"Pages S19-S20\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicology letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378427425016443\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378427425016443","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

根据欧洲化学品管理局(ECHA)于2022年发布的关于根据REACH进行的生殖毒性研究的剂量选择建议,本演讲将从3Rs(研究中动物的替代,减少和改进)和科学角度介绍这一建议的影响。ECHA的建议是在对现有的延长一代生殖毒性(EOGRT)研究的设计、实施和毒理学结果进行评估之后提出的,并担心由于剂量不足可能会错过潜在的危险影响。由此产生的建议明确规定,测试的最高剂量应“证明其目的是引起生殖毒性的明确证据,而不会使亲代动物产生过多的其他毒性和严重痛苦(例如,衰弱、严重食欲不振、作为严重痛苦迹象的过高死亡率),从而损害对共同发生的生殖影响的解释。”这些建议已由包括欧洲生态毒理学和化学品毒理学中心(ECETOC)剂量选择工作组在内的若干专家组根据经济合作与发展组织(OECD)现有试验指南和指导文件中的建议(包括关于人道终点和选择最大耐受剂量的建议)进行了评估。与剂量选择有关的其他考虑因素包括产妇临床毒性体征、食物消耗/营养摄入、临床化学参数、循环/心血管变化、靶器官毒性、产妇应激和毒性动力学等因素。这些评估的结果,以及最近与ECHA和更广泛的科学界(包括EUROTOX 2024卫星会议[3])的讨论,旨在更好地理解这些建议,将被提交,以确认确保高水平人类健康保护的共同目标,同时平衡科学实用主义和对动物福利的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
S06-01 Setting the scene: Dose level selection for development and reproductive toxicity studies
Following advice on dose selection issued by the European Chemicals Agency (ECHA) in 2022 [1] for reproductive toxicity studies conducted under REACH, this presentation will cover the implications of this advice from both a 3Rs (Replacement, Reduction and Refinement of animals in research) and scientific perspective. The ECHA advice followed an evaluation of existing extended one generation reproductive toxicity (EOGRT) studies with respect to design, conduct and toxicological findings, and concerns that potential hazardous effects could be missed due to inadequate dosing. The resulting advice specified that the highest dose tested should “demonstrate an aim to induce clear evidence of reproductive toxicity without excessive other toxicity and severe suffering in parental animals (e.g. prostration, severe inappetence (lack of appetite), excessive mortality as signs of severe suffering) that would compromise the interpretation of co-occurring reproductive effects.” These recommendations have been evaluated by a number of expert groups, including the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Task Force on Dose Selection [2], in relation to advice in existing Organisation for Economic Cooperation and Development (OECD) test guidelines and guidance document, including on humane endpoints and selection of the maximum tolerated dose. Other considerations relevant to dose selection include factors such as maternal clinical signs of toxicity, food consumption/nutritional intake, clinical chemistry parameters, circulatory/cardiovascular changes, target organ toxicity, maternal stress and toxicokinetics. The results of these evaluations, as well as recent discussions with ECHA and the wider scientific community (including at the EUROTOX 2024 satellite session [3]) which aimed to better understand the advice, will be presented, recognising a shared goal of ensuring a high level of human health protection whilst balancing scientific pragmatism and impact on animal welfare.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Toxicology letters
Toxicology letters 医学-毒理学
CiteScore
7.10
自引率
2.90%
发文量
897
审稿时长
33 days
期刊介绍: An international journal for the rapid publication of novel reports on a range of aspects of toxicology, especially mechanisms of toxicity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信